Overall survival with sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (mRCC)

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 5024-5024 ◽  
Author(s):  
R. A. Figlin ◽  
T. E. Hutson ◽  
P. Tomczak ◽  
M. D. Michaelson ◽  
R. M. Bukowski ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Overall Survival ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Pazopanib for the First-Line Treatment of Patients with Advanced and/or Metastatic Renal Cell Carcinoma

2012 ◽  
Vol 31 (1) ◽  
pp. 15-24 ◽  
Author(s):  
Mary Kilonzo ◽  
Jenni Hislop ◽  
Andrew Elders ◽  
Cynthia Fraser ◽  
Donald Bissett ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Sunitinib First-line Treatment in Metastatic Renal Cell Carcinoma: Costs and Effects

2019 ◽  
Vol 39 (10) ◽  
pp. 5559-5564 ◽  
Author(s):  
RIIKKA-LIISA VUORINEN ◽  
NIINA PAUNU ◽  
TAINA TURPEENNIEMI-HUJANEN ◽  
TAINA REUNAMO ◽  
ANTTI JEKUNEN ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document